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Abstract: 
Objective: The long term prognosis of patients with Complex Regional Pain 
Syndrome (CRPS) is unknown with no reported prospective studies from 
the UK longer than 18 months. The CRPS-UK Network aims to study this by 
use of a Registry. The aims of this paper are to outline the CRPS-UK 
Registry; assess the validity of the data; and to describe the characteristics 
of a sample of the UK CRPS population.  
Methods: A Web-based CRPS-UK Registry was developed and made 
accessible to centres experienced in diagnosing and managing patients 
with CRPS. Pragmatic annual follow-up questions were agreed.  
Results:  As from July 2013, the Registry has recruited 240 patients. A 
blinded, randomly selected, validation study demonstrated 95.6% 
completion and 99.4% accuracy of a random sample of the recorded data. 
These patients have chronic disease (median duration 29 months); 72.5% 
were female (2.6:1), with a mean age at symptoms onset of 43 years, and 
were left-handed more than expected (21.8% versus 10% in the general 
population). Patients reported a delayed diagnosis, with the median time 
between symptom onset and diagnosis of 6 months. Thirty patients 
(12.5%) had multiple limb involvement and most of them (83.3%) had 
either a unilateral or contralateral spread of CRPS.  
Conclusion: CRPS-UK Registry is a validated method for actively recruiting 
well-characterised patients with CRPS to provide further information on the 
long term outcome.  
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Abstract 
Objective: The long term prognosis of patients with Complex Regional Pain 
Syndrome (CRPS) is unknown with no reported prospective studies from the UK 
longer than 18 months. The CRPS-UK Network aims to study this by use of a 
Registry. The aims of this paper are to outline the CRPS-UK Registry; assess the 
validity of the data; and to describe the characteristics of a sample of the UK CRPS 
population. 
Methods: A Web-based CRPS-UK Registry was developed and made accessible to 
centres experienced in diagnosing and managing patients with CRPS. Pragmatic 
annual follow-up questions were agreed. 
Results:  As from July 2013, the Registry has recruited 240 patients. A blinded, 
randomly selected, validation study demonstrated 95.6% completion and 99.4% 
accuracy of a random sample of the recorded data. These patients have chronic 
disease (median duration 29 months); 72.5% were female (2.6:1), with a mean age at 
symptoms onset of 43 years, and were left-hand d more than expected (21.8% versus 
10% in the general population). Patients reported a delayed diagnosis, with the 
median time between symptom onset and diagnosis of 6 months. Thirty patients 
(12.5%) had multiple limb involvement and most of them (83.3%) had either a 
unilateral or contralateral spread of CRPS. 
Conclusion: CRPS-UK Registry is a validated method for actively recruiting well-
characterised patients with CRPS to provide further information on the long term 
outcome. 
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Introduction  
 
Complex Regional Pain Syndrome (CRPS) is a disabling, usually post-traumatic 
condition, characterised by severe pain and changes in the appearance of a limb (see 
Diagnostic Criteria). Community studies have demonstrated an incidence of CRPS of 
between 5 (USA) and 20 (The Netherlands) per 100,000 population, with 70-80% 
having resolution of their symptoms within 1 year [1,2]. Approximately 25% of 
patients will have unrelenting pain for more than 1 year after the onset of symptoms 
with effects on employment, quality of life, activities of daily living and mood. In the 
UK therefore, up to 10,000 adults have experienced CRPS for longer than 1 year. 
What is their prognosis?  
 
No UK prospective studies have followed patients with CRPS for more than 1 year 
after symptom onset despite the condition being significantly associated with a poor 
quality of life. In 2008, the CRPS-UK Network, a group of rheumatologists, 
anaesthetists, allied health professionals and researchers interested in this condition, 
established the CRPS-UK Registry. This 35-year proj ct will complement other 
international Registries; provide prognostic information for a cohort of patients 
diagnosed with CRPS in the UK in the 21
st
 Century; and provide a resource for 
further studying this condition. The aims of this paper are to outline the CRPS-UK 
Registry; assess the validity of the data; and to describe the characteristics of a sample 
of the UK CRPS population. 
 
Three prospective studies have examined long term outcomes of patients with CRPS. 
Vaneker et al followed 45 patients with upper limb CRPS diagnosed using the 
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Veldman criteria for 8 years using the validated Impairment Level Sumscore (ISS) 
[3]. Temperature and range of movement scores had improved whereas the global ISS 
had no significant change. In the randomised controlled trial by Kemler et al, 64 
patients with CRPS reported pain scores of 4-6/10, five years after recruitment [4]. 
Zyluk published a single-centre follow-up of 27/30 patients with reflex sympathetic 
dystrophy in Poland followed for 13 months on average [5]. Pain and swelling 
resolved but some patients were still functionally weak. Four retrospective reviews 
have noted the outcomes of patients with CRPS. Geertzen et al studied 65 patients 
finding that 62% of patients were still limited in their activities of daily living 5 years 
after diagnosis [6]. Galer et al surveyed 31 patients with a mean duration of 
symptoms of 3.3 years [7]. Pain levels ranged between 3.9-7.3/10 with an average of 
5.9. Field et al published a cohort of 100 Colles fracture patients with 55 having had a 
follow-up at 10 years [8]. 6 patients were identified to have finger stiffness 12 weeks 
after fracture. All 6 continued to have evidence of CRPS (algodystrophy) at 10 years. 
Finally, de Mos et al identified 102 CRPS patients from the Dutch general 
practitioners database who had had symptoms for an average of 5.8 years [9]. 16% 
reported the CRPS as still progressive and 31% were incapable of working.  
 
Taken together, these studies suggest a poor outcome for patients with CRPS existing 
more than one year. Poor follow-up, small numbers and inexact diagnostic criteria 
undermine these results. Research and diagnostic criteria have recently been 
published allowing more uniformity of study patients and thus comparison across data 
sets [10]. Patients’ prognoses may have improved as newer therapies including 
innovative rehabilitation strategies and pharmacotherapies become available. 
Furthermore, increased clinician awareness following the publication of the CRPS-
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UK Guidelines and earlier intervention may have improved the long term outcome for 
patients with CRPS [11]. A larger and more contemporary study is needed. 
 
 
Methods 
 
The CRPS-UK registry is based on EDGE, a Secure Socket Layer encrypted web-
based research management resource developed by the Cancer Research UK Clinical 
Centre, Clinical Informatics Research Unit, University of Southampton. Patients are 
fully consented to provide personal contact details to be uploaded to the registry by a 
clinician who has confirmed the clinical diagnosis. The CRPS-UK Registry is fully 
approved by NRES (REC No: 08/H0306/38) and sponsored by Cambridge University 
Hospitals NHS Foundation Trust. 
 
The diagnosis is confirmed by the application of the IASP (Budapest) diagnostic 
criteria (Harden) by a clinician experienced in the diagnosis and management of 
patients with CRPS. 
Diagnostic criteria for CRPS 
A history of symptoms or the presence of signs are assessed the following categories: 
Sensory: Hypersensitivity to sensations such as light touch; temperature; deep 
pressure; or pinprick. Allodynia or hyperalgesia. 
Vasomotor Temperature asymmetry; skin colour changes; skin colour asymmetry 
Sudomotor Oedema; sweating changes; sweating asymmetry 
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Motor/trophic Decreased range of motion; motor dysfunction (weakness, tremor, 
dystonia); trophic changes (hair, nail, skin) 
 
 
Diagnostic criteria for CRPS are met when symptoms in 3 domains are reported and 
signs in 2 domains are witnessed.  
Research criteria are met when symptoms in 4 domains are reported in the presence of 
signs in at least 2 domains. 
 
Patients with CRPS type 1 (no major nerve damage) and type 2 (major nerve damage) 
are recruited. Children under the age of 18 years require the consent of the responsible 
guardian or parent. It is recorded whether the patient meets diagnostic or research 
criteria on the Budapest definitions. This recruitment strategy ensures a reliably 
homogenous study population, although does not reflect the entirety of the population 
who develop CRPS. Patients with self-limiting CRPS or non-specific limb pain in the 
absence of vasomotor, trophic, motor and sudomotor changes are likely to be under-
represented in this Registry as they will be less likely to be referred to the centres who 
are actively recruiting.  
 
Up to 2013, recruitment to the registry was from 4 centres throughout the UK: 
Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath; 
Department of Pain Medicine, Walton Centre NHS Foundation Trust, Liverpool; 
Department of Rheumatology, Addenbrooke’s Hospital, Cambridge; Pain Clinic, 
Department of Anaesthetics, Derriford Hospital, Plymouth. All centres have local 
R&D committee approval to contribute to the Registry.  
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Data validation 
To determine the validity of the Registry data, a random sample of 20 patients (10 
each from 2 centres) was selected in 2011. This was performed by obtaining the 
previous 10 records that were available from each of the 2 centres.  Accuracy and 
completeness of all recorded variables were compared with the 'gold standard' 
medical records. Completeness was defined as the proportion of the data entered, and 
accuracy was defined as the percentage of the total data that correctly matched data 
from the medical record. In the CRPS-UK Registry, each patient has 37 variables 
recorded, thus giving at total of 740 data points to be analysed.  
 
Statistical analysis 
 Descriptive statistics were calculated for the demographic and baseline data of the 
cohort. Means, standard deviations and ranges were calculated for the continuous 
variable age; while medians, interquartile ranges (IQR) and ranges were calculated for 
the other variables since they exhibited a skewed distribution. Frequencies and 
percentages were calculated for the categorical variables. A binomial test was used to 
test against the null hypothesis that the percentage right handed in the CRPS registry 
is the same as that in the general population; and separately to test if the percentage of 
patients with diagonal collateral spread was significantly different from the 
percentage expected (33%). A Fisher’s Exact test was used to investigate any 
association between hand dominance and the first limb affected with CRPS. Statistical 
significance was concluded if p<0.05.  
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Results 
 
In July 2013, 240 patients with CRPS had been recruited. All fulfilled the diagnostic 
Budapest criteria for CRPS and 58 (24.2%) met the tighter research criteria. The 
demographic and disease related results are displayed in Table 1 and the patient 
symptoms and signs at the time of recruitment are displayed in Table 2.  
 
With respect to data validation, the completeness of the database was 95.6%, with an 
accuracy of 99.4%. This compares favourably with other published registries [12,13].   
 
The CRPS UK Registry is predominantly a female cohort (72.5%, 2.6:1) with the 
average age of symptom onset at 43 years (SD 12.7) and recruitment into the registry 
at 46 years (SD 12.3). Patients had had symptoms for an average of 29 months (IQR 
39.7) before being recruited into the Registry. The median self-reported time from 
onset of symptoms to diagnosis was 6 months (IQR 13.4). 
   
It is clear that this group of patients have ongoing symptoms despite having more than 
2 years of symptoms on average. More than 88% of the patients included in the 
database reported ongoing allodynia. A reduced range of movement and weakness 
were also very prevalent in this cohort with more than 89% of all patients reporting 
these symptoms and more than 83% of the cohort having these documented on 
examination. Dystonia was reported to be the least common motor symptom (27%), 
but when this was present only one patient reported a resolution. Vasomotor 
symptoms were again very common with more than 74% of patients reporting 
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oedema, skin colour and temperature asymmetry and this being witnessed in about 
60% of patients. Sweating was the least reported and witnessed sudomotor feature. 
Around one-third of patients reported trophic changes in each of the categories and 
around 30% of patients were seen to have these changes in each of the trophic 
categories upon recruitment.  
 
Of the 160 patients in whom original hand dominance was recorded, 133 (83.1%)were 
right handed. This is significantly lower than the average general population of 90% 
(p<0.01) [14]. CRPS affected 50.2% of the cohort’s right side first and 48.1% had 
their arm affected first rather than their leg. In the 133 right hand dominant patients, 
26 (19.5%) had their left arm affected; 44 (33.1%) right arm; 35 (26.3%)  left leg; and 
28 (21.1%) right leg. In the 27 left hand dominant patients, 9 (33.3%) had their left 
arm affected; 5 (18.5%) right arm; 8 (29.6%) left leg; and 5 (18.5%) right leg. Hence 
it can be seen that there was no laterality preference, nor limb preference, dependent 
upon whether a patient was right or left hand dominant. This was confirmed by a 
Fisher’s Exact test investigating if there was any association between hand dominance 
and first area affected (p=0.302). 
 
CRPS was diagnosed in more than one limb for 30/240 (12.5%) of patients in this 
cohort. Only 5/30 (16.7%) of patients had diagonal contralateral spread (e.g. right arm 
and left leg), half of what was expected (33%, p=0.054). 25/30 (83.3%) of patients 
with two limbs involved had had either a unilateral or contralateral spread of CRPS. 
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The commonest trigger for CRPS was soft tissue injury (29.2%) followed by fracture 
(28.0%) and then surgery (23.7%). There was a high reported ‘spontaneous’ onset of 
CRPS (15.7%). 
Discussion 
 
The inception of the CRPS-UK Registry following full ethical approval has been 
successful and this Registry intends to continue to recruit patients with chronic 
disease who are being managed in centres experienced in this condition. As from mid-
2013, the Registry has recruited 240 patients. These patients, with a mean age at 
symptoms onset of 43 years, had chronic disease (median duration 29 months); tended 
to be female (2.6:1), and were left-handed more than expected (21.8% versus 10% in 
the general population). Patients in the Registry often reported a delayed diagnosis, 
with the median time between symptom onset and diagnosis of 6 months.  Thirty 
patients (12.5%) had multiple limb involvement and the spread affected the 
contralateral diagonal limb less frequently than expected, although not significantly 
so. Most patients reported ongoing pain and signs and symptoms consistent with their 
diagnosis despite the average symptom duration of nearly two and a half years. 
 
In the Netherlands, de Mos et al reported that the average age of their cohort of 238 
patients was 52.7 (range 7-90 years old) with 77.3% female. Of this total, 74% were 
identified to be in secondary care and this group were slightly younger than those 
patients who remained in primary care (mean age 51.3 compared to 56.6 years). 
CRPS type II (underlying neural involvement) accounted for 2.9% of the cohort with 
the ratio of arm:leg involvement being 1.5:1. Fractures accounted for 44% of triggers. 
In 10.1% of the cohort, no obvious cause could be found to explain the onset of 
Page 9 of 19
http://mc.manuscriptcentral.com/bjpain
British Journal of Pain
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
CRPS.  In the US, Sandroni et al reported the average age of their cohort of 74 
patients with CRPS type I was 46.9 years (range 15-86 years) with 81.1% of the 
cohort female (4:1). 4.1% of the cohort had CRPS diagnosed at multiple sites and the 
ratio of arm:leg involvement was 2:1. A further 11 patients with CRPS type II were 
identified (12.9%). Fractures as the initial trigger accounted for 46%. No spontaneous 
onset cases were reported. In both studies, the peak incidence was between the ages of 
50-70 years old.  
 
When comparing the CRPS UK Registry to these two community-based studies, it is 
important to remember that these studies were designed to detect incident cases 
whereas the average duration of symptoms in the CRPS UK Registry population was 
nearly 3 years. Any potential differences between the community studies and the 
CRPS UK Registry population may therefore relate to poor prognostic factors. There 
are several notable differences. The CRPS UK Registry has a younger population 
with more male representation and more patients with multiple limb involvement. The 
CRPS-UK Registry also contains more patients with a spontaneous onset of their 
symptoms and a smaller proportion of patients with a fracture as a trigger. Finally, the 
CRPS-UK Registry has a greater proportion of patients with leg involvement (ratio of 
arm:leg 1:1). As expected, the Registry therefore differs from the community-based 
studies and suggests that risk factors for poor prognosis may include males; younger 
age of onset; spontaneous onset; leg; and multiple limb involvement.   
 
In the published literature, 28 prognostic factors, both physical and psychological, 
identified from 12 studies are known to be associated with the outcome of patients 
with CRPS [15]. These include age less than 40 years; an initial presentation with a 
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cold limb; the affected limb being a leg; more than 1 limb affected [16]; depression 
[17]; perceived lack of social support [17]; and the use of anger as an emotional 
regulator [18].  
 
The self-reported delay between the symptom onset and diagnosis is long on average 
and highly variable in the CRPS-UK Registry. This did not vary significantly between 
centres, so that local factors are not suspected. This does support the accepted view 
that a delay in diagnosis predisposes a patient to enter secondary and tertiary care for 
the management of their CRPS. This is an area that is worthy of further study. Given 
that community-based studies report that the symptoms of CRPS appear to self-limit 
in 70-80% of patients within the first year of onset, it would be important to make the 
correct diagnosis within 12 months to allow effective treatments and self-management 
to occur. Expert consensus states that early treatment is likely to improve long term 
outcomes although there is a paucity of data regarding this [19]. With the publication 
of the CRPS-UK Guidelines in 2011 (Royal College of Physicians), awareness and 
earlier diagnosis may be improved. It would be interesting to see whether the delay to 
diagnosis changes over time in the CRPS-UK Registry over the next five years. 
 
Patients with spontaneous onset of CRPS are recognised. This has previously been 
reported at the level of 5-10% [20]. Our data has a slightly higher prevalence of this 
group (15.7%). Perhaps this could be explained due to the chronic nature of this 
cohort of patients, suggesting a more severe phenotype. This is preliminary data and 
will need to be confirmed but perhaps suggests a different phenotype in this group of 
patients. This is supported by de Mos’ data, suggesting that patients with fracture 
have a better outcome than patients who have CRPS unrelated to a fracture [9].  
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The aetiology of CRPS has remained elusive. Neurological hypotheses have been 
proposed [21]. In the propagation of CRPS to multiple limbs, contralateral diagonal 
spread would be expected to occur less commonly. This was suggested by the CRPS-
UK Registry cohort and has previously been reported in a separate cohort [22]. Our 
data would therefore support a role for neural transmission in the spread of CRPS.  
 
The CRPS-UK Registry is only one a number of international registries. In the 
Netherlands, the TREND initiative has developed a network of interested clinicians 
and researchers with an active database of more than a thousand patients 
(www.trendconsortium.nl). In Switzerland, a specific CRPS registry has been 
established to capture patients who develop CRPS following trauma or orthopaedic 
procedures [23]. In the USA, the Reflex Sympathetic Dystrophy Syndrome 
Association sponsors a self-registry web portal for patients with CRPS to register with 
the intention of following them up for 20-years. The CRPS-UK Registry will 
contribute to these differing approaches to recruiting patients with CRPS and will 
provide novel data as well as allow the testing of hypotheses by recruiting patients 
into further studies. It is important to recognise the different patient populations that 
each Registry represents and this must be borne in mind when comparisons between 
data sets are made. 
 
Despite the good recruitment into the CRPS-UK Registry there will be concerns over 
the future validity of the data generated and its generalisability. Patients enrolled into 
the CRPS-UK Registry have had the condition for nearly three years and are younger 
than expected. This is therefore a chronic cohort and not representative of all patients 
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who are diagnosed with CRPS, as the majority improve within the first year of 
symptom onset. Recruitment will need to be sustained over more than a decade to 
provide meaningful results.  
 
In conclusion, the CRPS-UK Registry is actively recruiting well-characterised 
patients with CRPS to provide further information on the long term outcome. The 
cohort demonstrates that most continue to have ongoing symptoms and signs of the 
condition. Analysis demonstrates a well-validated cohort of patients who are willing 
to engage in being followed up. We hope that this will stimulate further research 
efforts in the UK for advancing the understanding and management of this 
challenging condition, and for the Registry to be available for comparisons with other 
international registries in due course. 
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Key Messages 
• Patients with Complex Regional Pain Syndrome can be recruited to the CRPS-
UK Registry 
• CRPS that lasts for more than one year continues with pain and associated 
signs 
• Chronic CRPS appears to occur more frequently in left-handed individuals  
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Table 1 Demographics and Baseline data of cohort 
 No. of recruited pts (%) 
Gender [N=240] 
       Male 
       Female 
 
66 (27.5) 
174 (72.5) 
Age at onset of symptoms (years) [N=239] Mean 43 years  
(range 12-78, SD 12.7) 
Duration of symptoms at recruitment (months) 
[N=237] 
 
Median 29 months  
(range 0-297, IQR 39.7)  
Delay between onset and diagnosis (months) 
[N=209] 
Median 6 months 
(range 0-129, IQR 13.4) 
 
Trigger [N=236] 
       Fracture 
       Soft tissue injury 
       Surgery 
       Spontaneous 
       Nerve injury 
       Electric injury 
Other 
 
66 (28.0) 
69 (29.2) 
56 (23.7) 
37 (15.7) 
5 (2.1) 
1 (0.4) 
2 (0.8) 
First limb affected [N=239] 
       Right arm 
       Left arm 
       Right leg 
       Left leg 
 
65 (27.2) 
50 (20.9) 
55 (23.0) 
69 (28.9)  
Hand dominance (original) [N=160] 
       Right 
 
133 (83.1) 
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       Left 27 (16.9) 
Hand dominance (current) [N=124] 
       Right 
       Left 
 
97 (78.2) 
27 (21.8) 
Second area (if any) affected [N=30] 
       Right arm 
       Left arm 
       Right leg 
       Left leg 
       Right eye and neck 
 
3 (10.0) 
6 (20.0) 
10 (33.3) 
10 (33.3) 
1 (3.3) 
Time between onset of symptoms in first limb 
and second area (months) [N=26] 
Median 15 months 
(range 0-130, IQR 29.5) 
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Table 2  Symptoms and signs at recruitment to the CRPS UK Registry 
 
 Symptoms (%) Signs (%) 
 N Now Previous Never N Now Absent Not 
tested 
Sensory  
Allodynia 232 206  
(88.8) 
19 
(8.2) 
7  
(3.0) 
237 205  
(86.5) 
28  
(11.8) 
4 
(1.7) 
Vasomotor  
Temperature 
asymmetry 
232 204  
(87.9) 
18  
(7.8) 
10  
(4.3) 
238 147 
(61.8) 
76 
(31.9) 
15 
(6.3) 
Skin colour 
asymmetry 
233 204  
(87.6) 
18  
(7.7) 
11  
(4.7) 
239 160  
(66.9) 
73  
(31.6) 
6 
(2.5) 
Oedema 230 172  
(74.8) 
49  
(21.3) 
9  
(3.9) 
234 137  
(58.5) 
93  
(39.8) 
4 
(1.7) 
Sweating 
asymmetry 
232 118  
(50.9) 
55  
(23.7) 
59  
(25.4) 
236 88 
(37.3) 
130  
(55.1) 
18  
(7.6) 
Motor  
 N Now Previous Never N Now  Absent Not 
tested 
Reduced ROM 230 206  
(89.5) 
16  
(7.0) 
8  
(3.5) 
239 208  
(87.0) 
27  
(11.3) 
4 
(1.7) 
Weakness 228 205  
(89.9) 
13  
(5.7) 
10  
(4.4) 
238 198  
(83.2) 
29  
(12.2) 
11  
(4.6) 
Tremor 229 83  
(36.3) 
57  
(24.9) 
89  
(38.8) 
237 67  
(28.3) 
147  
(62.0) 
23 
(9.7) 
Dystonia 227 62  
(27.3) 
57  
(25.1) 
108  
(47.6) 
236 60  
(25.4) 
150  
(63.6) 
26 
(11.0) 
Trophic  
 N Now Previous Never N Now  Absent Not 
tested 
Hair changes 231 71  
(30.7) 
73  
(31.6) 
87  
(37.7) 
235 66  
(28.1) 
148  
(63.0) 
21 
(8.9) 
Nail changes 233 94  
(40.3) 
61  
(26.2) 
78  
(33.5) 
237 72  
(30.4) 
143  
(61.3) 
22  
(9.3) 
Skin changes 230 101  
(43.9) 
54  
(23.5) 
75  
(32.6) 
238 91  
(38.2) 
128  
(53.8) 
19  
(8.0) 
         
ROM – range of movement 
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